Press release

27 | 04 | 12

GATC daughter LifeCodexx successfully completes clinical validation of its noninvasive prenatal test method of trisomy 21

GATC daughter LifeCodexx AG today announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing. First results from the prospective blinded multi-center study demonstrate highest clinical accuracy for...

28 | 03 | 12

GATC Biotech’s NightXpress sequencing service goes Europe-wide

New Cologne laboratories bring GATC Biotech closer to its customers

GATC Biotech, Europe’s leading sequencing provider, now offers its overnight sequencing service NightXpress Europe wide. This unique overnight service has been made possible by the recently opened European Custom Sequencing Centre in...

10 | 01 | 12

GATC Biotech and LifeCodexx complete recruitment of blood samples for clinical study of trisomy 21 diagnostic test

Results of study to be available in the first quarter 2012

GATC Biotech AG and its subsidiary LifeCodexx AG successfully completed the recruitment of over 500 blood samples required for the clinical study of the non-invasive prenatal diagnostic test for the...